Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Texas Crop Science Inc. is managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and are situated in 2 distinct art units. This distribution shows that the company's current prosecution workload is diversified across different examination groups rather than being concentrated in a single office location.
VIGIL, TORIANA NICHOLE is identified as the busiest examiner for this portfolio, holding 1 busiest examiner pending action. With a total of 2 pending office actions, the workload is divided among the 2 distinct examiners. Each examiner is operating within one of the 2 distinct art units mentioned in the data.
The fact that the pending office actions are spread across 2 distinct art units suggests that the company's Biotechnology & Pharmaceuticals filings cover varied subject matter that triggers different departmental reviews. Practitioners must account for the specific practices of the 2 distinct examiners in different environments. This creates a more complex prosecution landscape than a portfolio where all actions are centralized under a single art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIGIL, TORIANA NICHOLE | 1 | 53.1% | +24.1% |
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18382419 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | ARMSTRONG, SUSANNAH SIPPLE | 113d overdue |
| 18384266 | WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | VIGIL, TORIANA NICHOLE | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18384266 | WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | VIGIL, TORIANA NICHOLE | 1612 | §103 | Final Rejection | — | Pending | Oct 26, 2023 |
| 18382419 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103§112DP | Final Rejection | 113d overdue | Pending | Oct 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial